What Does It Really Mean to Say That a Patient With a Hematologic Malignancy Is “Cured”?
European Journal of Haematology · 2026-07 · 117 (1) · 5-8
DOI: 10.1111/ejh.70213 ↗Kurz gefasst
Editorial in der Zeitschrift European Journal of Haematology, online erschienen am 13.05.2026. Verfasst von Fortunato Morabito und 3 weiteren Autor:innen. Beteiligte Einrichtung: AIL Sezione di Cosenza, cosenza, Italy. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- AIL Sezione di Cosenza, cosenza, Italy.
- Hematology Unit, Department of Onco-Hematology, AO of Cosenza, Cosenza, Italy.
- Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy.
ORCID-Profile: Massimo Gentile
Zitieren
APA
Morabito, F., Vigna, E., Martino, E. A., & Gentile, M. (2026). What Does It Really Mean to Say That a Patient With a Hematologic Malignancy Is “Cured”?. European Journal of Haematology, 117(1), 5-8. https://doi.org/10.1111/ejh.70213
Vancouver
Morabito F, Vigna E, Martino EA, Gentile M. What Does It Really Mean to Say That a Patient With a Hematologic Malignancy Is “Cured”?. European Journal of Haematology. 2026;117(1):5-8. doi:10.1111/ejh.70213
BibTeX
@article{Morabito2026,
author = {Morabito, Fortunato and Vigna, Ernesto and Martino, Enrica Antonia and Gentile, Massimo},
title = {What Does It Really Mean to Say That a Patient With a Hematologic Malignancy Is “Cured”?},
journal = {European Journal of Haematology},
year = {2026},
volume = {117},
number = {1},
pages = {5--8},
doi = {10.1111/ejh.70213}
}
EUVIMED